期刊
CURRENT CANCER DRUG TARGETS
卷 14, 期 3, 页码 294-309出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009614666140305222328
关键词
Breast cancer; chemokine; CXCL3; migration; proteomics; secretome
类别
资金
- National University of Singapore (NUS)
- CBRG grant - National Medical Research Council, Ministry of Health, Singapore
Secreted proteins are an attractive minefield for cancer drug targets. An iTRAQ-based tandem mass spectrometry approach was employed to relatively quantify proteins in the secretomes of four isogenic breast cancer cell lines with increasing metastatic potential. CXCL3 was found to be upregulated in aggressive cancer cells. SiRNA and antibody neutralization studies supported a role of CXCL3 in metastatic processes. Meta-analysis of the mRNA level of CXCL3 in 1881 breast tumors supported a role of CXCL3 in clinical breast cancer. Our results support a functional role of CXCL3 in breast cancer metastasis and as a viable target for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据